Corneal implant for swelling of the cornea
Part of Eyes & vision, Genetic & congenital clinical trials.
This trial tests a new corneal implant to treat corneal swelling caused by Fuchs' dystrophy or after cataract surgery. It aims to improve vision and reduce the need for a full corneal transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older
- You have corneal swelling due to Fuchs' dystrophy or after cataract surgery
- You have had cataract surgery with a lens implant in the eye being treated
- Your vision in the treated eye is between counting fingers and about 6/12 (moderately blurred)
- Your cornea is thicker than 0.6 mm (measured by a special scan)
- You have not had other eye surgeries besides routine cataract surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This study tests an artificial corneal implant called EndoArt for people with long-term corneal swelling who have run out of transplant options. The implant aims to reduce swelling and improve vision without needing a donor cornea.
This trial tests an investigational cell therapy called EO2002 for people with corneal edema (swelling of the clear front part of the eye) caused by endothelial dysfunction, which can happen with Fuchs dystrophy or after cataract surgery. The treatment aims to restore the inner layer of the cornea to reduce swelling and improve vision.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This Phase 1 trial tests a new, lab-made tissue transplant to improve corneal clarity in people with certain types of corneal endothelium failure (eye swelling) caused by specific conditions. The main goal is to check safety and see if vision and corneal health improve.
This trial looks at how to manage medicine around DMEK corneal transplant surgery to improve eye outcomes and safety. It may help people having this specific type of cornea transplant by testing an approach in the time after surgery.
Hear when a new Corneal Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.